Becker RV - Search Results

1

Analysis of real-world length of stay data and costs associated with use of autologous skin cell suspension for the treatment of small burns in U.S. centers.

Carson JS, Carter JE, Hickerson WL, Rae L, Saquib SF, Wibbenmeyer LA, Becker RV, Sparks JA, Walsh TP. Carson JS, et al. Among authors: becker rv. Burns. 2023 May;49(3):607-614. doi: 10.1016/j.burns.2022.11.007. Epub 2022 Dec 5. Burns. 2023. PMID: 36813602 Free article.

2

Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers.

Carter JE, Carson JS, Hickerson WL, Rae L, Saquib SF, Wibbenmeyer LA, Becker RV, Walsh TP, Sparks JA. Carter JE, et al. Among authors: becker rv. Adv Ther. 2022 Nov;39(11):5191-5202. doi: 10.1007/s12325-022-02306-y. Epub 2022 Sep 14. Adv Ther. 2022. PMID: 36103088 Free PMC article.

3

Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States.

Le QA, Hay JW, Becker R, Wang Y. Le QA, et al. Ann Pharmacother. 2019 Feb;53(2):134-143. doi: 10.1177/1060028018798034. Epub 2018 Aug 30. Ann Pharmacother. 2019. PMID: 30160186 Free PMC article.

4

The cost offsets and cost-effectiveness associated with pegylated drugs: a review of the literature.

Becker R, Dembek C, White LA, Garrison LP. Becker R, et al. Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):775-93. doi: 10.1586/erp.12.65. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 23252359 Review.

5

Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.

Vega C, Becker RV, Mucha L, Lorenz BH, Eaddy MT, Ogbonnaya AO. Vega C, et al. Among authors: becker rv. Curr Med Res Opin. 2017 Oct;33(10):1879-1889. doi: 10.1080/03007995.2017.1347092. Epub 2017 Aug 2. Curr Med Res Opin. 2017. PMID: 28644095

6

The cost of hospitalization in Crohn's disease.

Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. Cohen RD, et al. Among authors: becker rv. Am J Gastroenterol. 2000 Feb;95(2):524-30. doi: 10.1111/j.1572-0241.2000.01779.x. Am J Gastroenterol. 2000. PMID: 10685762

7

The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.

Conti RM, Padula WV, Becker RV, Salamone S. Conti RM, et al. Among authors: becker rv. J Manag Care Spec Pharm. 2021 Aug;27(8):1077-1085. doi: 10.18553/jmcp.2021.27.8.1077. J Manag Care Spec Pharm. 2021. PMID: 34337991 Free PMC article.

8

Advances in the management of Crohn's disease: economic and clinical potential of infliximab.

Hanauer SB, Cohen RD, Becker RV 3rd, Larson LR, Vreeland MG. Hanauer SB, et al. Among authors: becker rv 3rd. Clin Ther. 1998 Sep-Oct;20(5):1009-28. doi: 10.1016/s0149-2918(98)80082-9. Clin Ther. 1998. PMID: 9829451 Review.

9

Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.

Atsou K, Ereshefsky L, Brignone M, Danchenko N, Diamand F, Mucha L, Touya M, Becker R, François C. Atsou K, et al. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):29-42. doi: 10.1080/14737167.2021.1855979. Epub 2021 Jan 17. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 33307885

10

Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.

Deitelzweig SB, Becker R, Lin J, Benner J. Deitelzweig SB, et al. Thromb Haemost. 2008 Nov;100(5):810-20. Thromb Haemost. 2008. PMID: 18989525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters